Generali Investments Towarzystwo Funduszy Inwestycyjnych
Position in PFE — Pfizer Inc
CIK 2043130
WARSAW, R9
Position in PFE
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$2,094,960
+$508,440 QoQ
Shares Held
87,000
+54.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#939
of 2,821 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Generali Investments Towarzystwo Funduszy Inwestycyjnych holds $8,405,860 across 8 Drug Manufacturers - General names. PFE ranks #1 (24.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
This page
|
87,000 | $2,094,960 | |
| 2 | LLY |
ELI LILLY & Co
|
1,510 | $1,811,139 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,000 | $1,799,000 | |
| 4 | AMGN |
Amgen Inc
|
2,500 | $905,300 | |
| 5 | JNJ |
Johnson & Johnson
|
3,100 | $787,307 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
10,500 | $605,010 | |
| 7 | ABBV |
AbbVie Inc.
|
1,100 | $276,804 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,000 | $126,340 |
All Filings in PFE
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,094,960 | 87,000 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,586,520 | 56,500 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,406,850 | 56,500 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,350,440 | 53,000 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,236,240 | 51,000 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,178,310 | 46,500 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,191,197 | 44,900 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $425,418 | 14,700 | Shares | Sole | 2025-02-05 | |
| 2024-06-30 | $408,508 | 14,600 | Shares | Sole | 2025-02-05 | |
| 2024-03-31 | $388,500 | 14,000 | Shares | Sole | 2025-02-05 | |
| 2023-12-31 | $403,060 | 14,000 | Shares | Sole | 2025-02-05 | |
| 2023-09-30 | $464,380 | 14,000 | Shares | Sole | 2025-02-05 | |
| 2023-06-30 | $572,208 | 15,600 | Shares | Sole | 2025-02-05 | |
| 2023-03-31 | $465,120 | 11,400 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||